New Insights into the Regulation of Na + ,K + -ATPase by Ouabain

International Review of Cell and Molecular Biology

Volumn 294, Issue , 2012, Pages 99-132

  Silva, Elisabete ^a   Soares da Silva, Patrício ^a  

^a University of Porto   (Portugal)

Author keywords

Cardiac glycosides; Ouabain; PLasmERosome; Signaling pathways; Signalosome

Indexed keywords

ADAPTOR PROTEIN; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATE; APOPTOSIS SIGNAL REGULATING KINASE 1; BUFADIENOLIDE; CARDENOLIDE; CARDIAC GLYCOSIDE; CAVEOLIN; DIGOXIN; EPIDERMAL GROWTH FACTOR RECEPTOR; GLYCOGEN SYNTHASE KINASE 3; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OUABAIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C; POTASSIUM ION; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE A; REACTIVE OXYGEN METABOLITE; SODIUM ION; STEROID;

ACTIVE IMMUNIZATION; ADRENAL CORTEX; ADRENAL MEDULLA; APOPTOSIS; ARTICLE; BINDING AFFINITY; BLOOD PRESSURE REGULATION; BLOOD VESSEL TONE; CALCIUM SIGNALING; CELL ACTIVATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM FUNCTION; CHEMICAL STRUCTURE; CONGESTIVE HEART FAILURE; CYTOPLASM; DIGITALIS LANATA; DIGITALIS PURPUREA; DISEASE SEVERITY; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; ENZYME SYNTHESIS; EXOCYTOSIS; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE OVERLOAD; HUMAN; HYPERTENSION; IN VITRO STUDY; IN VIVO STUDY; ION TRANSPORT; KIDNEY FAILURE; KIDNEY MASS; MOLECULAR INTERACTION; NATRIURESIS; NEOPLASM; NONHUMAN; PLANT; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; SODIUM CALCIUM EXCHANGE; SODIUM EXCRETION; SODIUM INTAKE; UPREGULATION; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

EID: 84857375068     PISSN: 19376448     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-394305-7.00002-1     Document Type: Chapter

References (206)

1. Aizman O., Uhlen P., Lal M., Brismar H., Aperia A. Ouabain, a steroid hormone that signals with slow calcium oscillations. Proc. Natl. Acad. Sci. USA 2001, 98:13420-13424.
2. Albers R.W. Biochemical aspects of active transport. Annu. Rev. Biochem. 1967, 36:727-756.
3. Aperia A. Regulation of sodium/potassium ATPase activity: impact on salt balance and vascular contractility. Curr. Hypertens. Rep. 2001, 3:165-171.
4. Aronson J.K. Account of the Foxglove and Its Medical Uses 1986, 1785-1985. Oxford University Press, USA.
5. + -ATPase β3 subunit. The presence of β3 in lung and liver addresses the problem of the missing subunit. J. Biol. Chem. 1997, 272:22405-22408.
6. + -ATPase β2-subunit gene. Gene 1998, 208:221-227.
7. + -ATPase inhibition during voluntary hypoventilation. Hypertension 1995, 26:781-788.
8. + -ATPase inhibitors, marinobufagenin and ouabain, on isolated rat aorta. Eur. J. Pharmacol. 1995, 274:151-158.
9. + -ATPase inhibitor in patients after acute myocardial infarction. Hypertension 1998, 31:1097-1103.
10. + -ATPase, is a novel factor in pathogenesis of diabetes mellitus. Dokl. Biol. Sci. 2005, 404:333-337.
11. Bagrov A.Y., Shapiro J.I., Fedorova O.V. Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets. Pharmacol. Rev. 2009, 61:9-38.
12. Balzan S., Neglia D., Ghione S., D'Urso G., Baldacchino M.C., Montali U., et al. Increased circulating levels of ouabain-like factor in patients with asymptomatic left ventricular dysfunction. Eur. J. Heart Fail. 2001, 3:165-171.
13. + -ATPase inhibits the activity of the enzyme. Proc. Natl. Acad. Sci. USA 1991, 88:11359-11362.
14. + -ATPase: heterogeneity in structure, diversity in function. Am. J. Physiol. 1998, 275:633-650.
15. 2+ exchanger and TRPC proteins. Biochim. Biophys. Acta 2010, 1802:1219-1229.
16. Blaustein M.P., Juhaszova M., Golovina V.A. The cellular mechanism of action of cardiotonic steroids: a new hypothesis. Clin. Exp. Hypertens. 1998, 20:691-703.
17. Brismar H., Holtback U., Aperia A. Mechanisms by which intrarenal dopamine and ANP interact to regulate sodium metabolism. Clin. Exp. Hypertens. 2000, 22:303-307.
18. Brocardo P.S., Budni J., Pavesi E., Franco J.L., Uliano-Silva M., Trevisan R., et al. Folic acid administration prevents ouabain-induced hyperlocomotion and alterations in oxidative stress markers in the rat brain. Bipolar Disord. 2010, 12:414-424.
19. Butt A.N., Semra Y.K., Ho C.S., Swaminathan R. Effect of high salt intake on plasma and tissue concentration of endogenous ouabain-like substance in the rat. Life Sci. 1997, 61:2367-2373.
20. + -ATPase. J. Cell Biol. 2008, 182:1153-1169.
21. + -ATPase. Am. J. Physiol. 1995, 269:637-643.
22. + -ATPase activity. Role of actin phosphorylation. Ann. N. Y. Acad. Sci. 1997, 834:559-561.
23. Cantley L.C. The phosphoinositide 3-kinase pathway. Science 2002, 296:1655-1657.
24. Chen K.K., Kovarikova A. Pharmacology and toxicology of toad venom. J. Pharm. Sci. 1967, 56:1535-1541.
25. + -ATPase and ouabain/related cardiac glycosides: a new paradigm for development of anti-breast cancer drugs?. Breast Cancer Res. Treat. 2006, 96:1-15.
26. + -ATPase in cultured renal epithelial cells. J. Biol. Chem. 2008, 283:1128-1136.
27. Cheung W.J., Kent M.A., El-Shahat E., Wang H., Tan J., White R., et al. Central and peripheral renin-angiotensin systems in ouabain-induced hypertension. Am. J. Physiol. Heart Circ. Physiol. 2006, 291:624-630.
28. 3 subunit (CD298): association with alpha subunit and expression on peripheral blood cells. Tissue Antigens 2006, 68:509-517.
29. + -ATPase and dopamine receptor molecules induced by changes in intracellular sodium concentration of renal epithelial cells. Am. J. Physiol. Renal Physiol. 2008, 295:1117-1125.
30. i . Am. J. Physiol. 1992, 262:754-762.
31. Cook S.J., Wakelam M.J. Phospholipases C and D in mitogenic signal transduction. Rev. Physiol. Biochem. Pharmacol. 1992, 119:13-45.
32. Cornelius F., Mahmmoud Y.A. Functional modulation of the sodium pump: the regulatory proteins " Fixit" News Physiol. Sci. 2003, 18:119-124.
33. Correa Gde R., Cunha K.C., dos Santos A.A., de Araujo E.G. The trophic effect of ouabain on retinal ganglion cell is mediated by EGF receptor and PKC delta activation. Neurochem. Res. 2010, 35:1343-1352.
34. + -ATPase. Sci. STKE 2003, 2003:RE1.
35. D'Urso G., Frascarelli S., Balzan S., Zucchi R., Montali U. Production of ouabain-like factor in normal and ischemic rat heart. J. Cardiovasc. Pharmacol. 2004, 43:657-662.
36. Dekker L.V., Parker P.J. Protein kinase C-a question of specificity. Trends Biochem. Sci. 1994, 19:73-77.
37. + -ATPase α-subunit. Proc. Natl. Acad. Sci. USA 1994, 91:2965-2969.
38. Dikalov S.I., Dikalova A.E., Bikineyeva A.T., Schmidt H.H., Harrison D.G., Griendling K.K. Distinct roles of Nox1 and Nox4 in basal and angiotensin II stimulated superoxide and hydrogen peroxide production. Free Radic. Biol. Med. 2008, 45:1340-1351.
39. Doris P.A., Bagrov A.Y. Endogenous sodium pump inhibitors and blood pressure regulation: an update on recent progress. Proc. Soc. Exp. Biol. Med. 1998, 218:156-167.
40. 2+ exchanger in heart. J. Biol. Chem. 2004, 279:54053-54061.
41. + -ATPase mediates ouabain-induced hypertension in mice and increased vascular contractility in vitro. Am. J. Physiol. Heart Circ. Physiol. 2005, 288:477-485.
42. + -ATPase plays a role in blood pressure regulation. Proc. Natl. Acad. Sci. USA 2005, 102:15845-15850.
43. + -ATPase activity. FEBS Lett. 1999, 456:45-48.
44. + -ATPase molecules to the plasma membrane. Biochemistry 2000, 39:9884-9892.
45. + regulates dopamine and angiotensin II receptors availability at the plasma membrane and their cellular responses in renal epithelia. J. Biol. Chem. 2003, 278:28719-28726.
46. + -ATPase trafficking in response to GPCR signals and intracellular sodium. Circ. Res. 2004, 95:1100-1108.
47. el-Masri M.A., Clark B.J., Qazzaz H.M., Valdes R. Human adrenal cells in culture produce both ouabain-like and dihydroouabain-like factors. Clin. Chem. 2002, 48:1720-1730.
48. + -ATPase: mechanisms underlying rapid and sustained changes in pump activity. Am. J. Physiol. 1995, 269:C295-C311.
49. Fedorova O.V., Shapiro J.I., Bagrov A.Y. Endogenous cardiotonic steroids and salt-sensitive hypertension. Biochim. Biophys. Acta 2010, 1802:1230-1236.
50. Feraille E., Doucet A. Sodium-potassium-adenosinetriphosphatase-dependent sodium transport in the kidney: hormonal control. Physiol. Rev. 2001, 81:345-418.
51. + -ATPase: relation to genetic hypertension. Am. J. Physiol. 1999, 277:1338-1349.
52. Ferrandi M., Molinari I., Barassi P., Minotti E., Bianchi G., Ferrari P. Organ hypertrophic signaling within caveolae membrane subdomains triggered by ouabain and antagonized by PST 2238. J. Biol. Chem. 2004, 279:33306-33314.
53. Ferrandi M., Manunta P., Ferrari P., Bianchi G. The endogenous ouabain: molecular basis of its role in hypertension and cardiovascular complications. Front. Biosci. 2005, 10:2472-2477.
54. Ferrandi M., Molinari I., Bianchi G., Ferrari P. Ouabain-dependent signaling in caveolae as a novel therapeutic target for hypertension. Cell. Mol. Biol. 2006, 52:15-18.
55. Ferrari P., Torielli L., Ferrandi M., Padoani G., Duzzi L., Florio M., et al. PST2238: a new antihypertensive compound that antagonizes the long-term pressor effect of ouabain. J. Pharmacol. Exp. Ther. 1998, 285:83-94.
56. + -ATPase in genetic hypertension. J. Pharmacol. Exp. Ther. 1999, 288:1074-1083.
57. Ferrari P., Ferrandi M., Valentini G., Manunta P., Bianchi G. Targeting ouabain- and adducin-dependent mechanisms of hypertension and cardiovascular remodeling as a novel pharmacological approach. Med. Hypotheses 2007, 68:1307-1314.
58. Frey R.S., Ushio-Fukai M., Malik A.B. NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology. Antioxid. Redox Signal. 2009, 11:791-810.
59. + -ATPase. Am. J. Physiol. Renal Physiol. 2006, 290:241-250.
60. + -ATPase subunits. Curr. Opin. Nephrol. Hypertens. 2008, 17:526-532.
61. + -ATPase. Ann. N. Y. Acad. Sci. 2003, 986:388-394.
62. Güntert T.W., Linde H.H. Cardiac glycosides: prerequisites for the development of new cardiotonic compounds. Experientia. 1977, 33:697-703.
63. + -ATPase and endogenous digitalis-like compounds in depressive disorders. Biol. Psychiatry 2006, 60:491-499.
64. Goldstein I., Lax E., Gispan-Herman I., Ovadia H., Rosen H., Yadid G., et al. Neutralization of endogenous digitalis-like compounds alters catecholamines metabolism in the brain and elicits anti-depressive behavior. Eur. Neuropsychopharmacol. 2011, 10.1016/j.euroneuro.2011.05.007.
65. + -ATPase activity. Am. J. Physiol. Renal Physiol. 2002, 282:1084-1096.
66. Goto A., Ishiguro T., Yamada K., Ishii M., Yoshioka M., Eguchi C., et al. Isolation of a urinary digitalis-like factor indistinguishable from digoxin. Biochem. Biophys. Res. Commun. 1990, 173:1093-1101.
67. Gottlieb S.S., Rogowski A.C., Weinberg M., Krichten C.M., Hamilton B.P., Hamlyn J.M. Elevated concentrations of endogenous ouabain in patients with congestive heart failure. Circulation 1992, 86:420-425.
68. + -ATPase. J. Biol. Chem. 2000, 275:27832-27837.
69. + -ATPase and the epidermal growth factor receptor relays the signal from ouabain to mitogen-activated protein kinases. J. Biol. Chem. 2002, 277:18694-18702.
70. + with monensin. Am. J. Physiol. 1987, 253:26-33.
71. Hamlyn J.M., Manunta P. Endogenous ouabain: a link between sodium intake and hypertension. Curr. Hypertens. Rep. 2011, 13:14-20.
72. Hamlyn J.M., Blaustein M.P., Bova S., DuCharme D.W., Harris D.W., Mandel F., et al. Identification and characterization of a ouabain-like compound from human plasma. Proc. Natl. Acad. Sci. USA 1991, 88:6259-6263.
73. Haux J., Klepp O., Spigset O., Tretli S. Digitoxin medication and cancer; case control and internal dose-response studies. BMC Cancer 2001, 1:11.
74. Ho C.S., Butt A., Semra Y.K., Swaminathan R. Effect of carbidopa on the excretion of sodium, dopamine, and ouabain-like substance in the rat. Hypertension 1997, 30:1544-1548.
75. + -ATPase through a sodium/hydrogen exchanger-1 (NHE-1)-dependent mechanism in human kidney proximal tubule cells. Am. J. Physiol. Renal Physiol. 2010, 299:77-90.
76. Huang B.S., Leenen F.H. Sympathoexcitatory and pressor responses to increased brain sodium and ouabain are mediated via brain ANG II. Am. J. Physiol. 1996, 270:275-280.
77. + -ATPase a-subunit isoform gene expressions in cardiac myocytes by ouabain and other hypertrophic stimuli. J. Mol. Cell. Cardiol. 1997, 29:3157-3167.
78. Huang L., Li H., Xie Z. Ouabain-induced hypertrophy in cultured cardiac myocytes is accompanied by changes in expression of several late response genes. J. Mol. Cell. Cardiol. 1997, 29:429-437.
79. Huang B.S., Ahmadi S., Ahmad M., White R.A., Leenen F.H. Central neuronal activation and pressor responses induced by circulating ANG II: role of the brain aldosterone-" ouabain" pathway. Am. J. Physiol. Heart Circ. Physiol. 2010, 299:422-430.
80. Hubbard P.C., Henderson I.W. Renal dopamine and the tubular handling of sodium. J. Mol. Endocrinol. 1995, 14:139-155.
81. Hussain T., Lokhandwala M.F. Renal dopamine receptor function in hypertension. Hypertension 1998, 32:187-197.
82. Ihenetu K., Qazzaz H.M., Crespo F., Fernandez-Botran R., Valdes R. Digoxin-like immunoreactive factors induce apoptosis in human acute T-cell lymphoblastic leukemia. Clin. Chem. 2007, 53:1315-1322.
83. Jaitovich A., Bertorello A.M. Intracellular sodium sensing: SIK1 network, hormone action and high blood pressure. Biochim. Biophys. Acta 2010, 1802:1140-1149.
84. + -ATPase and hypertension. Life Sci. 2010, 86:73-78.
85. Jiang X., Ren Y.P., Lv Z.R. Ouabain induces cardiac remodeling in rats independent of blood pressure. Acta Pharmacol. Sin. 2007, 28:344-352.
86. + -ATPase in the kidney. Kidney Int. 1986, 29:10-20.
87. + pump alpha subunit isoforms in plasmalemma. Physiological implications. Ann. N. Y. Acad. Sci. 1997, 834:524-536.
88. + -ATPase. Annu. Rev. Biochem. 2002, 71:511-535.
89. Kashkin V.A., Zvartau E.E., Fedorova O.V., Bagrov Y.Y., Lakatta E.G., Bagrov A.Y. Endogenous bufadienolide mediates pressor response to ethanol withdrawal in rats. Eur. Neuropsychopharmacol. 2008, 18:74-77.
90. Kawamura A., Guo J., Itagaki Y., Bell C., Wang Y., Haupert G.T., et al. On the structure of endogenous ouabain. Proc. Natl. Acad. Sci. USA 1999, 96:6654-6659.
91. Khundmiri S.J., Metzler M.A., Ameen M., Amin V., Rane M.J., Delamere N.A. Ouabain induces cell proliferation through calcium-dependent phosphorylation of Akt (protein kinase B) in opossum kidney proximal tubule cells. Am. J. Physiol. Cell Physiol. 2006, 291:1247-1257.
92. Khundmiri S.J., Amin V., Henson J., Lewis J., Ameen M., Rane M.J., et al. Ouabain stimulates protein kinase B (Akt) phosphorylation in opossum kidney proximal tubule cells through an ERK-dependent pathway. Am. J. Physiol. Cell Physiol. 2007, 293:1171-1180.
93. Komiyama Y., Nishimura N., Munakata M., Mori T., Okuda K., Nishino N., et al. Identification of endogenous ouabain in culture supernatant of PC12 cells. J. Hypertens. 2001, 19:229-236.
94. + -ATPase is associated with moesin. Eur. J. Cell Biol. 2003, 82:87-92.
95. Kuznetsova T., Manunta P., Casamassima N., Messaggio E., Jin Y., Thijs L., et al. Left ventricular geometry and endogenous ouabain in a Flemish population. J. Hypertens. 2009, 27:1884-1891.
96. + -ATPase mediates variable nociceptive sensitivity in the formalin test. Pain 2009, 144:294-302.
97. Laredo J., Hamilton B.P., Hamlyn J.M. Ouabain is secreted by bovine adrenocortical cells. Endocrinology 1994, 135:794-797.
98. Laredo J., Hamilton B.P., Hamlyn J.M. Secretion of endogenous ouabain from bovine adrenocortical cells: role of the zona glomerulosa and zona fasciculata. Biochem. Biophys. Res. Commun. 1995, 212:487-493.
99. Laredo J., Shah J.R., Lu Z.R., Hamilton B.P., Hamlyn J.M. Angiotensin II stimulates secretion of endogenous ouabain from bovine adrenocortical cells via angiotensin type 2 receptors. Hypertension 1997, 29:401-407.
100. + -ATPase and Related ATPases 2000, 671-679. Elsevier Science, Amsterdam. K. Taniguchi, S. Kayas (Eds.).
101. + -ATPase is the putative membrane receptor of hormone ouabain. Commun. Integr. Biol. 2010, 3:625-628.
102. Lee Y.K., Ng K.M., Lai W.H., Man C., Lieu D.K., Lau C.P., et al. Ouabain facilitates cardiac differentiation of mouse embryonic stem cells through ERK1/2 pathway. Acta Pharmacol. Sin. 2011, 32:52-61.
103. 1 subunit of the sodium pump to combat glioblastoma cells. Neurosurgery 2008, 62:211-221.
104. + -ATPase/Src complex and cardiotonic steroid-activated protein kinase cascades. Pflugers Arch. 2009, 457:635-644.
105. Li J., Zelenin S., Aperia A., Aizman O. Low doses of ouabain protect from serum deprivation-triggered apoptosis and stimulate kidney cell proliferation via activation of NF-kB. J. Am. Soc. Nephrol. 2006, 17:1848-1857.
106. + -ATPase using RNA interference assay. J. Biol. Chem. 2006, 281:19709-19719.
107. + -ATPase. J. Biol. Chem. 2007, 282:10585-10593.
108. Lichtstein D., Gati I., Samuelov S., Berson D., Rozenman Y., Landau L., et al. Identification of digitalis-like compounds in human cataractous lenses. Eur. J. Biochem. 1993, 216:261-268.
109. Lichtstein D., Steinitz M., Gati I., Samuelov S., Deutsch J., Orly J. Biosynthesis of digitalis-like compounds in rat adrenal cells: hydroxycholesterol as possible precursor. Life Sci. 1998, 62:2109-2126.
110. + -ATPase inhibitors: biosynthesis in bovine and rat adrenals. Clin. Exp. Hypertens. 1998, 20:573-579.
111. Lin Y., Dubinsky W.P., Ho D.H., Felix E., Newman R.A. Determinants of human and mouse melanoma cell sensitivities to oleandrin. J. Exp. Ther. Oncol. 2008, 7:195-205.
112. + -ATPase subunitst. J. Exp. Ther. Oncol. 2010, 8:271-286.
113. Liu J., Xie Z.J. The sodium pump and cardiotonic steroids-induced signal transduction protein kinases and calcium-signaling microdomain in regulation of transporter trafficking. Biochim. Biophys. Acta 2010, 1802:1237-1245.
114. 1 and MDCK cells. Kidney Int. 2002, 62:2118-2125.
115. Liu P., Rudick M., Anderson R.G. Multiple functions of caveolin-1. J. Biol. Chem. 2002, 277:41295-41298.
116. + -ATPase in LLC-PK1 cells requires caveolin-1. Kidney Int. 2005, 67:1844-1854.
117. Liu L., Zhao X., Pierre S.V., Askari A. Association of PI3K-Akt signaling pathway with digitalis-induced hypertrophy of cardiac myocytes. Am. J. Physiol. Cell Physiol. 2007, 293:1489-1497.
118. + -ATPase generates calcium oscillations in hippocampal astrocytes. Neuroreport 2007, 18:597-600.
119. + -ATPase/inositol 1,4,5-trisphosphate receptor signaling microdomain. J. Biol. Chem. 2008, 283:11461-11468.
120. Lopatina E.V., Karetsky A.V., Penniyaynen V.A., Vinogradova T.V. Role of cardiac glycosides in regulation of the growth of retinal tissue explants. Bull. Exp. Biol. Med. 2008, 146:744-746.
121. Lopez-Lazaro M., Pastor N., Azrak S.S., Ayuso M.J., Austin C.A., Cortes F. Digitoxin inhibits the growth of cancer cell lines at concentrations commonly found in cardiac patients. J. Nat. Prod. 2005, 68:1642-1645.
122. + -ATPase enhances natriuretic response to saline load. J. Am. Soc. Nephrol. 2008, 19:1947-1954.
123. + -ATPase subunit. Am. J. Physiol. Heart Circ. Physiol. 2008, 295:273-280.
124. Ludens J.H., Clark M.A., DuCharme D.W., Harris D.W., Lutzke B.S., Mandel F., et al. Purification of an endogenous digitalislike factor from human plasma for structural analysis. Hypertension 1991, 17:923-929.
125. + -ATPase in rat adipocytes. Relation to insulin stimulation of the enzyme. J. Biol. Chem. 1985, 260:1177-1184.
126. Manunta P., Stella P., Rivera R., Ciurlino D., Cusi D., Ferrandi M., et al. Left ventricular mass, stroke volume, and ouabain-like factor in essential hypertension. Hypertension 1999, 34:450-456.
127. Manunta P., Hamilton B.P., Hamlyn J.M. Salt intake and depletion increase circulating levels of endogenous ouabain in normal men. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006, 290:553-559.
128. Manunta P., Hamlyn J.M., Simonini M., Messaggio E., Lanzani C., Bracale M., et al. Endogenous ouabain and the renin-angiotensin-aldosterone system: distinct effects on Na handling and blood pressure in human hypertension. J. Hypertens. 2011, 29:349-356.
129. Mathews W.R., DuCharme D.W., Hamlyn J.M., Harris D.W., Mandel F., Clark M.A., et al. Mass spectral characterization of an endogenous digitalis like factor from human plasma. Hypertension 1991, 17:930-935.
130. 1 subunit of the sodium pump could represent a novel target to combat non-small cell lung cancers. J. Pathol. 2007, 212:170-179.
131. + -ATPase and inositol 1,4,5-trisphosphate receptor generates calcium oscillations. J. Biol. Chem. 2003, 278:50355-50361.
132. Murrell J.R., Randall J.D., Rosoff J., Zhao J.L., Jensen R.V., Gullans S.R., et al. Endogenous ouabain: upregulation of steroidogenic genes in hypertensive hypothalamus but not adrenal. Circulation 2005, 112:1301-1308.
133. + -ATPase activity. J. Cell. Physiol. 2005, 205:278-285.
134. + -ATPase and implications for the organization of membrane domains in polarized cells. Nature 1987, 328:533-536.
135. Nesher M., Dvela M., Igbokwe V.U., Rosen H., Lichtstein D. Physiological roles of endogenous ouabain in normal rats. Am. J. Physiol. Heart Circ. Physiol. 2009, 297:2026-2034.
136. Nikitina E.R., Mikhailov A.V., Nikandrova E.S., Frolova E.V., Fadeev A.V., Shman V.V., et al. In preeclampsia endogenous cardiotonic steroids induce vascular fibrosis and impair relaxation of umbilical arteries. J. Hypertens. 2011, 29:769-776.
137. Nishizuka Y. The Albert Lasker Medical Awards. The family of protein kinase C for signal transduction. JAMA 1989, 262:1826-1833.
138. Oudit G.Y., Sun H., Kerfant B.G., Crackower M.A., Penninger J.M., Backx P.H. The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease. J. Mol. Cell. Cardiol. 2004, 37:449-471.
139. + -ATPase by dopamine in proximal tubule epithelial cells. Semin. Nephrol. 2005, 25:322-327.
140. 2+ -dependent expressions of early-response genes in cardiac myocytes. J. Biol. Chem. 1996, 271:10372-10378.
141. Perrin A., Brasmes B., Chambaz E.M., Defaye G. Bovine adrenocortical cells in culture synthesize an ouabain-like compound. Mol. Cell. Endocrinol. 1997, 126:7-15.
142. Pierdomenico S.D., Bucci A., Manunta P., Rivera R., Ferrandi M., Hamlyn J.M., et al. Endogenous ouabain and hemodynamic and left ventricular geometric patterns in essential hypertension. Am. J. Hypertens. 2001, 14:44-50.
143. + -ATPase receptor complex: its organization and membership. Cell Biochem. Biophys. 2006, 46:303-316.
144. Podar K., Tai Y.T., Cole C.E., Hideshima T., Sattler M., Hamblin A., et al. Essential role of caveolae in interleukin-6- and insulin-like growth factor I-triggered Akt-1-mediated survival of multiple myeloma cells. J. Biol. Chem. 2003, 278:5794-5801.
145. Post R.L., Hegyvary C., Kume S. Activation by adenosine triphosphate in the phosphorylation kinetics of sodium and potassium ion transport adenosine triphosphatase. J. Biol. Chem. 1972, 247:6530-6540.
146. 2+ transporters in arterial smooth muscle from ouabain-induced hypertensive rats. Am. J. Physiol. Heart Circ. Physiol. 2010, 298:263-274.
147. + -ATPase function in caveolin-1 knockout cardiac fibroblasts. J. Mol. Cell. Cardiol. 2010, 49:525-531.
148. Razani B., Woodman S.E., Lisanti M.P. Caveolae: from cell biology to animal physiology. Pharmacol. Rev. 2002, 54:431-467.
149. Salardi S., Modica R., Ferrandi M., Ferrari P., Torielli L., Bianchi G. Characterization of erythrocyte adducin from the Milan hypertensive strain of rats. J. Hypertens. Suppl. 1988, 6:196-198.
150. + -ATPase α2 isoform confer ouabain resistance and result in abnormal behavior in mice. Synapse 2011, 65:520-531.
151. + -ATPase in the cardiotonic action of cardiac glycosides. Prog. Clin. Biol. Res. 1988, 268B:321-338.
152. Shah J.R., Laredo J., Hamilton B.P., Hamlyn J.M. Effects of angiotensin II on sodium potassium pumps, endogenous ouabain, and aldosterone in bovine zona glomerulosa cells. Hypertension 1999, 33:373-377.
153. + -ATPase α-subunit gene is expressed in testis. Proc. Natl. Acad. Sci. USA 1994, 91:12952-12956.
154. + -ATPase activity. J. Biol. Chem. 1990, 265:5166-5169.
155. Sich B., Kirch U., Tepel M., Zidek W., Schoner W. Pulse pressure correlates in humans with a proscillaridin A immunoreactive compound. Hypertension 1996, 27:1073-1078.
156. + -ATPase in opossum kidney cells. J. Cell. Physiol. 2009, 221:318-324.
157. + -ATPase in opossum kidney cells by ouabain. J. Cell. Physiol. 2011, 226:2391-2397.
158. + -ATPase parallels the increase in sodium transport and potassium recycling in an in vitro model of proximal tubule cellular ageing. J. Membr. Biol. 2006, 212:163-175.
159. + -ATPase in Wistar rats. FASEB J. 2007, 21:A1363-A1364.
160. + -ATPase. Life Sci. 2011, 88:719-724.
161. Sjostrom M., Stenstrom K., Eneling K., Zwiller J., Katz A.I., Takemori H., et al. SIK1 is part of a cell sodium-sensing network that regulates active sodium transport through a calcium-dependent process. Proc. Natl. Acad. Sci. USA 2007, 104:16922-16927.
162. Skou J.C. The influence of some cations on an adenosine triphosphatase from peripheral nerves. Biochim. Biophys. Acta 1957, 23:394-401.
163. 2 subunits to specialized plasma membrane microdomains. J. Biol. Chem. 2006, 281:12929-12940.
164. + -ATPase in polarized cells. Am. J. Physiol. Cell Physiol. 2008, 295:1202-1214.
165. Stenkvist B. Is digitalis a therapy for breast carcinoma?. Oncol. Rep. 1999, 6:493-496.
166. Stenkvist B., Bengtsson E., Eriksson O., Holmquist J., Nordin B., Westman-Naeser S. Cardiac glycosides and breast cancer. Lancet 1979, 1:563.
167. Stenstrom K., Takemori H., Bianchi G., Katz A.I., Bertorello A.M. Blocking the salt-inducible kinase 1 network prevents the increases in cell sodium transport caused by a hypertension-linked mutation in human α-adducin. J. Hypertens. 2009, 27:2452-2457.
168. Sweadner K.J., Rael E. The FXYD gene family of small ion transport regulators or channels: cDNA sequence, protein signature sequence, and expression. Genomics 2000, 68:41-56.
169. + -ATPase by salt-inducible kinase. Biochem. Biophys. Res. Commun. 2010, 393:339-344.
170. Therien A.G., Blostein R. Mechanisms of sodium pump regulation. Am. J. Physiol. Cell Physiol. 2000, 279:541-566.
171. + -ATPase. J. Biol. Chem. 1998, 273:23952-23958.
172. + -ATPase and calcium-signaling microdomains. Physiology 2008, 23:205-211.
173. + -ATPase forms a functional signaling complex. Mol. Biol. Cell 2006, 17:317-326.
174. Tian J., Li X., Liang M., Liu L., Xie J.X., Ye Q., et al. Changes in sodium pump expression dictate the effects of ouabain on cell growth. J. Biol. Chem. 2009, 284:14921-14929.
175. Torielli L., Tivodar S., Montella R.C., Iacone R., Padoani G., Tarsini P., et al. α-Adducin mutations increase Na/K pump activity in renal cells by affecting constitutive endocytosis: implications for tubular Na reabsorption. Am. J. Physiol. Renal Physiol. 2008, 295:478-487.
176. Tripodi G., Piscone A., Borsani G., Tisminetzky S., Salardi S., Sidoli A., et al. Molecular cloning of an adducin-like protein: evidence of a polymorphism in the normotensive and hypertensive rats of the Milan strain. Biochem. Biophys. Res. Commun. 1991, 177:939-947.
177. Tripodi G., Valtorta F., Torielli L., Chieregatti E., Salardi S., Trusolino L., et al. Hypertension-associated point mutations in the adducin α and β subunits affect actin cytoskeleton and ion transport. J. Clin. Invest. 1996, 97:2815-2822.
178. + -ATPase in rat brain. J. Biol. Chem. 1989, 264:8271-8280.
179. + -ATPase β1 subunit in pump sorting and epithelial integrity. J. Bioenerg. Biomembr. 2007, 39:367-372.
180. 2 isoform in salt-dependent hypertension. Pathophysiology 2007, 14:213-220.
181. Van Huysse J.W., Hou X. Pressor response to CSF sodium in mice: mediation by a ouabain-like substance and renin-angiotensin system in the brain. Brain Res. 2004, 1021:219-231.
182. Vanhaesebroeck B., Leevers S.J., Ahmadi K., Timms J., Katso R., Driscoll P.C., et al. Synthesis and function of 3-phosphorylated inositol lipids. Annu. Rev. Biochem. 2001, 70:535-602.
183. Vanourkova Z., Kramer H.J., Huskova Z., Vaneckova I., Opocensky M., Chabova V.C., et al. AT1 receptor blockade is superior to conventional triple therapy in protecting against end-organ damage in Cyp1a1-Ren-2 transgenic rats with inducible hypertension. J. Hypertens. 2006, 24:2465-2472.
184. + -ATPase. J. Biol. Chem. 2004, 279:17250-17259.
185. + -ATPase have increased susceptibility to pressure overload-induced cardiac hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 2011, 300:347-355.
186. Winnicka K., Bielawski K., Bielawska A., Surazynski A. Antiproliferative activity of derivatives of ouabain, digoxin and proscillaridin A in human MCF-7 and MDA-MB-231 breast cancer cells. Biol. Pharm. Bull. 2008, 31:1131-1140.
187. + -ATPase. J. Biol. Chem. 2000, 275:20693-20699.
188. + -ATPase-mediated signal transduction. Ann. N. Y. Acad. Sci. 2003, 986:497-503.
189. + -ATPase as a signal transducer. Eur. J. Biochem. 2002, 269:2434-2439.
190. + -ATPase-mediated signal transduction: from protein interaction to cellular function. Mol. Interv. 2003, 3:157-168.
191. + -ATPase α1 subunit of hepatoma HepG2 cell line to induce apoptosis and cell cycle arresting. Biol. Pharm. Bull. 2010, 33:743-751.
192. Xu Z.W., Wang F.M., Gao M.J., Chen X.Y., Shan N.N., Cheng S.X., et al. Cardiotonic steroids attenuate ERK phosphorylation and generate cell cycle arrest to block human hepatoma cell growth. J. Steroid Biochem. Mol. Biol. 2011, 125:181-191.
193. + -ATPase alpha subunits as drug targets. Mol. Cancer Ther. 2009, 8:2319-2328.
194. Ye Q., Li Z., Tian J., Xie J.X., Liu L., Xie Z. Identification of a potential receptor that couples ion transport to protein kinase activity. J. Biol. Chem. 2011, 286:6225-6232.
195. Yoshika M., Komiyama Y., Konishi M., Akizawa T., Kobayashi T., Date M., et al. Novel digitalis-like factor, marinobufotoxin, isolated from cultured Y-1 cells, and its hypertensive effect in rats. Hypertension 2007, 49:209-214.
196. Yoshika M., Komiyama Y., Takahashi H. Isolation of marinobufotoxin from the supernatant of cultured PC12 cells. Clin. Exp. Pharmacol. Physiol. 2011, 38:334-337.
197. + -ATPase tethers phospholipase C and IP3 receptor into a calcium-regulatory complex. Mol. Biol. Cell 2005, 16:4034-4045.
198. + -ATPase α subunit and regulates its trafficking. Proc. Natl. Acad. Sci. USA 2000, 97:6556-6561.
199. + -ATPase. Proc. Natl. Acad. Sci. USA 1992, 89:99-103.
200. + -ATPase in HK-2 cells is reduced by ouabain. Clin. Exp. Pharmacol. Physiol. 2010, 37:613-618.
201. + -ATPase. J. Biol. Chem. 1998, 273:18681-18684.
202. 2 subunits control myogenic tone and blood pressure in mice. J. Physiol. 2005, 569:243-256.
203. + -ATPase catalytic subunit as a signal transducer. J. Biol. Chem. 2006, 281:21954-21962.
204. Zhang H., Qian D.Z., Tan Y.S., Lee K., Gao P., Ren Y.R., et al. Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth. Proc. Natl. Acad. Sci. USA 2008, 105:19579-19586.
205. 1 receptor levels in rats. J. Comp. Physiol. B 2010, 180:117-124.
206. + -ATPase by low potassium requires reactive oxygen species. Am. J. Physiol. Cell Physiol. 2003, 285:319-326.